Nocturnal itch: Why do we itch at night?

Acta Dermato-Venereologica

Volumn 87, Issue 4, 2007, Pages 295-298

  Patel, Tejesh ^a   Ishiuji, Yozo ^a   Yosipovitch, Gil ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

Circadian rhythms; Mechanisms; Nocturnal itch; Nocturnal pruritus; Skin physiology; Treatment

Indexed keywords

ANTIHISTAMINIC AGENT; BUTORPHANOL; CALCINEURIN INHIBITOR; CORTICOSTEROID; EMOLLIENT AGENT; MELATONIN; MIRTAZAPINE; CYTOKINE; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOLOGICAL ADJUVANT; OPIATE RECEPTOR; PROSTAGLANDIN;

CIRCADIAN RHYTHM; MEDIATOR; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; REVIEW; SKIN FUNCTION; SKIN TEMPERATURE; SLEEP DISORDER; AUTONOMIC NERVOUS SYSTEM; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; THERMOREGULATION;

ADJUVANTS, IMMUNOLOGIC; AUTONOMIC NERVOUS SYSTEM; CIRCADIAN RHYTHM; CYTOKINES; EMOLLIENTS; HISTAMINE H1 ANTAGONISTS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MELATONIN; PHOTOTHERAPY; PITUITARY-ADRENAL SYSTEM; PROSTAGLANDINS; PRURITUS; QUALITY OF LIFE; RECEPTORS, OPIOID; SKIN TEMPERATURE; SLEEP DISORDERS; WATER LOSS, INSENSIBLE;

EID: 35348873737     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0280     Document Type: Review

References (49)

1. Yosipovitch G. Pruritus. An Update. Curr Probl Dermatol 2003; 15: 135-164.
2. Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol 2000; 143: 969-973.
3. Yosipovitch G, Goon AT, Wee J, Chan YH, Zucker I, Goh CL. Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus. Int J Dermatol 2002; 41: 212-216.
4. Yosipovitch G, Ansari N, Goon A, Chan YH, Goh CL. Clinical characteristics of pruritus in chronic idiopathic urticaria. Br J Dermatol 2002; 147: 32-36.
5. Koca R, Altin R, Konuk N, Altinyazar HC, Kart L. Sleep disturbance in patients with lichen simplex chronicus and its relationship to nocturnal scratching: a case control study. South Med J 2006; 99: 482-485.
6. Chouela E, Abeldano A, Pellerano G, Hernandez MI. Diagnosis and treatment of scabies: a practical guide. Am J Clin Dermatol 2002; 3: 9-18.
7. Dar NR, Akhter A. Clinical characteristics of uremic pruritus in patients undergoing haemodialysis. J Coll Physicians Surg Pak 2006; 16: 94-96.
8. Stadie V, Marsch WC. Itching attacks with generalized hyperhydrosis as initial symptoms of Hodgkin's disease. J Eur Acad Dermatol Venereol 2003; 17: 559-561.
9. Benjamin K, Waterston K, Russell M, Schofield O, Diffey B, Rees JL. The development of an objective method for measuring scratch in children with atopic dermatitis suitable for clinical use. J Am Acad Dermatol 2004; 50: 33-40.
10. Bender BG, Leung SB, Leung DY. Actigraphy assessment of sleep disturbance in patients with atopic dermatitis: an objective life quality measure. J Allergy Clin Immunol 2003; 111: 598-602.
11. Dahl RE, Bernhisel-Broadbent J, Scanlon-Holdford S, Sampson HA, Lupo M. Sleep disturbances in children with atopic dermatitis. Arch Pediatr Adolesc Med 1995; 149: 856-860.
12. Dahl RE. The impact of inadequate sleep on children's daytime cognitive function. Semin Pediatr Neurol 1996; 3: 44-50.
13. Aoki T, Kushimoto H, Hishikawa Y, Savin JA. Nocturnal scratching and its relationship to the disturbed sleep of itchy subjects. Clin Exp Dermatol 1991; 16: 268-272.
14. Savin JA, Paterson WD, Oswald I, Adam K. Further studies of scratching during sleep. Br J Dermatol 1975; 93: 297-302.
15. Monti JM, Vignale R, Monti D. Sleep and nighttime pruritus in children with atopic dermatitis. Sleep 1989; 12: 309-314.
16. Dawn A, Yosipovitch G. Treating itch in psoriasis. Dermatol Nurs 2006; 18: 227-233.
17. Yosipovitch G, Xiong GL, Haus E, Sackett-Lundeen L, Ashkenazi I, Maibach HI. Time-dependent variations of the skin barrier function in humans: transepidermal water loss, stratum corneum hydration, skin surface pH, and skin temperature. J Invest Dermatol 1998; 110: 20-23.
18. Lee CH, Chuang HY, Shih CC, Jong SB, Chang CH, Yu HS. Transepidermal water loss, serum IgE and beta-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis. Br J Dermatol 2006; 154: 1100-1107.
19. Yosipovitch G. Dry skin and impairment of barrier function associated with itch - new insights. Int J Cosmet Sci 2004; 26: 1-7.
20. Cormia FE. Experimental histamine pruritus. I. Influence of physical and psychological factors on threshold reactivity. J Invest Dermatol 1952; 19: 21-34.
21. Ikoma A, Steinhoff M, Stander S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci 2006; 7: 535-547.
22. Glinski W, Brodecka H, Glinska-Ferenz M, Kowalski D. Increased concentration of beta-endorphin in the sera of patients with severe atopic dermatitis. Acta Derm Venereol 1995; 75: 9-11.
23. Bigliardi-Qi M, Lipp B, Sumanovski LT, Buechner SA, Bigliardi PL. Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis. Dermatology 2005; 210: 91-99.
24. Labrecque G, Vanier MC. Biological rhythms in pain and in the effects of opioid analgesics. Pharmacol Ther 1995; 68: 129-147.
25. Schwarz W, Birau N, Hornstein OP, Heubeck B, Schonberger A, Meyer C, Gottschalk J. Alterations of melatonin secretion in atopic eczema. Acta Derm Venereol 1988; 68: 224-229.
26. Harris CD. Neurophysiology of sleep and wakefulness. Respir Care Clin N Am 2005; 11: 567-586.
27. Hilton MF, Umali MU, Czeisler CA, Wyatt JK, Shea SA. Endogenous circadian control of the human autonomic nervous system. Comput Cardiol 2000; 27: 197-200.
28. Steinhoff M, Bienenstock J, Schmelz M, Maurer M, Wei E, Biro T. Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol 2006; 126: 1705-1718.
29. Lissoni P, Rovelli F, Brivio F, Brivio O, Fumagalli L. Circadian secretions of IL-2, IL-12, IL-6 and IL-10 in relation to the light/dark rhythm of the pineal hormone melatonin in healthy humans. Nat Immun 1998; 16: 1-5.
30. Yosipovitch G, Yosipovitch Z, Harell D, Ashkenazi I, Erman A. Diurnal rhythm of prostanoid secretion from bone/marrow organ in the rat. Bone 1995; 17: 79-83.
31. Ciabattoni G, Tamburrelli F, Greco F. Increased prostacyclin biosynthesis in patients with osteoid osteoma. Eicosanoids 1991; 4: 165-167.
32. Shih LY, Shih HN, Chen TH. Bone resorption activity of osteolytic metastatic lung and breast cancers. J Orthop Res 2004; 22: 1161-1167.
33. Honma Y, Arai I, Hashimoto Y, Futaki N, Sugimoto M, Tanaka M, Nakaike S. Prostaglandin D2 and prostaglandin E2 accelerate the recovery of cutaneous barrier disruption induced by mechanical scratching in mice. Eur J Pharmacol 2005; 518: 56-62.
34. Belgrade MJ. Following the clues to neuropathic pain. Distribution and other leads reveal the cause and the treatment approach. Postgrad Med 1999; 106: 127-140.
35. Shvartzman P. Pain management. In: Rakel R, editor. Saunders Manual of Medical Practice. Philadelphia: W.B. Saunders Company, 2000, p. 43-45.
36. Krishnan A, Koo J. Psyche, opioids, and itch: therapeutic consequences. Dermatol Ther 2005; 18: 314-322.
37. Klein PA, Clark RA. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 1999; 135: 1522-1525.
38. Krause L, Shuster S. Mechanism of action of antipruritic drugs. BMJ 1983; 287: 1199-1200.
39. Ebata T, Izumi H, Aizawa H, Kamide R, Niimura M. Effects of nitrazepam on nocturnal scratching in adults with atopic dermatitis: a double-blind placebo-controlled crossover study. Br J Dermatol 1998; 138: 631-634.
40. Hundley JL, Yosipovitch G. Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study. J Am Acad Dermatol 2004; 50: 889-891.
41. Dawn AG, Yosipovitch G. Butorphanol for treatment of intractable pruritus. J Am Acad Dermatol 2006; 54: 527-531.
42. Steinhoff M, Neisius U, Ikoma A, Fartasch M, Heyer G, Skov PS, et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003; 23: 6176-6180.
43. Ruzicka T, Bieber T, Schopf E, Rubins A, Dobozy A, Bos JD, et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 1997; 337: 816-821.
44. Leo HL, Bender BG, Leung SB, Tran ZV, Leung DY. Effect of pimecrolimus cream 1% on skin condition and sleep disturbance in children with atopic dermatitis. J Allergy Clin Immunol 2004; 114: 691-693.
45. Richardson GS. The human circadian system in normal and disordered sleep. J Clin Psychiatry 2005; 66 Suppl 9: 3-9.
46. Buijs RM, Scheer FA, Kreier F, Yi C, Bos N, Goncharuk VD, Kalsbeek A. Organization of circadian functions: interaction with the body. Prog Brain Res 2006; 153: 341-360.
47. Lewy AJ, Emens J, Jackman A, Yuhas K. Circadian uses of melatonin in humans. Chronobiol Int 2006; 23: 403-412.
48. Bergasa NV, Link MJ, Keogh M, Yaroslavsky G, Rosenthal RN, McGee M. Pilot study of bright-light therapy reflected toward the eyes for the pruritus of chronic liver disease. Am J Gastroenterol 2001; 96: 1563-1570.
49. Garfinkel D, Laudon M, Nof D, Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995; 346: 541-544.